Literature DB >> 9845284

Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells.

W W Zhang1, H Lempessi, Y Olsson.   

Abstract

Cerebral amyloid angiopathies comprise a heterogeneous group of conditions characterised by amyloid deposition in leptomeningeal and cortical vessels. We have studied the deposition of extracellular matrix components in such vessels from controls and ten cases with marked amyloid angiopathy. Arterial vessels which were heavily loaded with amyloid often showed lack of immunostaining to collagen type I, III, V and VI in the amyloid-containing parts of the vessel wall but some immunoreactivity remained in the adventitia. The subintimal region of some arterioles presented a faint staining with collagen V and collagen VI antisera. Immunostaining to collagen IV and laminin revealed normal reactivity in the vascular basal lamina and frequently remaining activity in the media. Immunostaining for actin showed a complete or partial loss of reactivity in the amyloid-containing parts of the media but often there was a thin line of staining at the position of pericytes. The endothelial markers did not reveal any changes compared with controls. In other cerebral microangiopathies, for instance Binswanger's leukoencephalopathy, CADASIL and cases presenting hyalinosis there is a deposition of fibrillary collagens in the wall of afflicted microvessels. Degeneration of smooth muscle cells and absence of marked fibrosis in some of the arterial vessels in cases of amyloid angiopathy may explain why such vessels are susceptible to ruptures and haemorrhages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845284     DOI: 10.1007/s004010050935

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

Review 1.  Aging and the neurovascular unit.

Authors:  Gregory J del Zoppo
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

2.  Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant.

Authors:  Francisco J Muñoz; Carlos Opazo; Gabriel Gil-Gómez; Gladys Tapia; Virginia Fernández; Miguel A Valverde; Nibaldo C Inestrosa
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

3.  Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Authors:  Zhiping Mi; Willi Halfter; Eric E Abrahamson; William E Klunk; Chester A Mathis; Elliott J Mufson; Milos D Ikonomovic
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-21       Impact factor: 3.685

4.  The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.

Authors:  Shino Magaki; Zhaoyi Tang; Spencer Tung; Christopher K Williams; Darrick Lo; William H Yong; Negar Khanlou; Harry V Vinters
Journal:  Neurobiol Aging       Date:  2018-06-11       Impact factor: 4.673

Review 5.  Endothelial cells and human cerebral small vessel disease.

Authors:  Atticus H Hainsworth; Asho T Oommen; Leslie R Bridges
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

6.  Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 mice.

Authors:  Micha M M Wilhelmus; Osoul Chouchane; Maarten Loos; Cornelis A M Jongenelen; John J P Brevé; Allert Jonker; John G J M Bol; August B Smit; Benjamin Drukarch
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-23       Impact factor: 6.250

Review 7.  Overlapping Protein Accumulation Profiles of CADASIL and CAA: Is There a Common Mechanism Driving Cerebral Small-Vessel Disease?

Authors:  Kelly Z Young; Gang Xu; Simon G Keep; Jimo Borjigin; Michael M Wang
Journal:  Am J Pathol       Date:  2020-12-30       Impact factor: 4.307

Review 8.  Collagen VI in healthy and diseased nervous system.

Authors:  Ilaria Gregorio; Paola Braghetta; Paolo Bonaldo; Matilde Cescon
Journal:  Dis Model Mech       Date:  2018-05-31       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.